DNA X, Inc.
For the period ended Jun 30, 2026. Filed Aug 19, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 19, 2026
SONM$2.35+5.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
| Three Months Ended · Six Months Ended | ||||
|---|---|---|---|---|
| June 30, | June 30, | |||
| 2026 | 2025 | 2026 | 2025 | |
| Continuing operations | ||||
| Net revenues | $— | $— | $— | $— |
| Operating expenses | ||||
| General and administrative | 1,278 | 1,471 | 4,896 | 2,341 |
| Total operating expenses | 1,278 | 1,471 | 4,896 | 2,341 |
| Net loss from operations | (1,278) | (1,471) | (4,896) | (2,341) |
| Interest expense, net | (140) | (389) | (271) | (480) |
| Loss on remeasurement of derivative liability | (11) | — | (238) | — |
| Gain on extinguishment of debt | 191 | — | 191 | — |
| Equity income from DNA X LLC | — | — | 48 | — |
| Net loss from continuing operations before income taxes | (1,238) | (1,860) | (5,166) | (2,821) |
| Income tax benefit from continuing operations | — | — | — | — |
| Net loss from continuing operations | (1,238) | (1,860) | (5,166) | (2,821) |
| Discontinued operations | ||||
| Income (loss) from discontinued operations | (9) | (5,615) | 10,259 | (4,196) |
| Net income (loss) | $(1,247) | $(7,475) | $5,093 | $(7,017) |
| Net income (loss) per share basic and diluted: | ||||
| Continuing operations* | $(0.91) | $(3.52) | $(3.95) | $(6.61) |
| Discontinued operations* | $(0.01) | $(10.63) | $7.84 | $(9.82) |
| Net income (loss)* | $(0.92) | $(14.15) | $3.89 | $(16.43) |
| Weighted-average shares used in computing net income (loss) per share: | ||||
| Basic | 1,350,914 | 528,367 | 1,308,227 | 426,962 |
| Diluted | 1,350,914 | 528,367 | 1,308,227 | 426,962 |
| * | Adjusted retroactively to reflect the 1-for-18 reverse stock split that became effective on October 28, 2025, see Note 1. |
|---|
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements*.*
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.